Restek
Home / Resource Hub / Technical Literature Library / Une seule analyse, une seule colonne, et moins de 9 minutes pour plus de 60 antibiotiques de différentes classes

Une seule analyse, une seule colonne, et moins de 9 minutes pour plus de 60 antibiotiques de différentes classes

Application phare : Antibiotiques vétérinaires de différentes classes sur Raptor C18 par LC-MS/MS

articleBanner
  • Excellente séparation des composés et temps d’analyse rapides.
  • Polyvalente et applicable à tout type d’analyse de résidus d’antibiotiques — et optimisation possible pour la quantification individuelle de panels de différentes classes :
    • Macrolide, Lincosamide, et Streptogramine (Figure 1)
    • Amphénicol et Tétracycline (Figure 2)
    • Quinolone (Figure 3)
    • Pénicilline, Céphalosporine, et Tétracycline (Figure 4)
    • Sulfonamide (Figure 5) (pour les ionophores, utiliser la colonne Raptor Biphenyl. [Figure 6])
 

L’utilisation d’antibiotiques sur les animaux élevés pour la consommation humaine est une préoccupation de Santé Publique et de sécurité en raison de la génération potentielle de bactéries résistantes aux médicaments. De nombreux pays dans l’Union Européenne ainsi que le Canada ont interdit l’utilisation d’antibiotiques à des fins non thérapeutiques, et les États-Unis définissent une politique visant à réduire l’utilisation d’antibiotiques médicalement importants pour stimuler la croissance. Afin de réglementer l’usage approprié des antibiotiques vétérinaires, la FDA aux États-Unis a fixé des limites maximales pour les résidus (MRL – "Maximum Residue Limits") pour différents tissus animaux et produits alimentaires (21 CFR Part 556). Une méthode analytique sensible, efficace et fiable pour différentes classes d’antibiotiques est donc nécessaire pour répondre à ces exigences réglementaires, et la colonne LC Restek Raptor C18 est la colonne idéale pour cela.

cgarm-img
LC_FS0506
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Desacetyl cephapirin0.70150382.03111.92124.21
2.Sulfanilamide0.85200172.9893.0775.23
3.Amoxicillin0.92100366.24349.10208.07
4.Cephapirin1.3650424.17292.08124.14
5.Tildipirosin1.38200734.59561.45204.15
6.Desfuroyl ceftiofur cysteine disulfide1.40300549.16183.02126.00
7.Lincomycin1.5050407.32359.23389.28
8.Sulfadiazine1.5720251.18156.0492.08
9.Cefquinome1.73200529.19134.10125.12
10.Ampicillin1.7850350.19106.07160.06
11.Sulfathiazole1.7910256.16156.0392.08
12.Marbofloxacin1.8110363.2072.11320.10
13.Cefalexin1.82100348.10158.05174.05
14.Sulfapyridine1.8610250.13156.1092.08
15.Norfloxacin1.9620320.23276.20233.13
16.Ofloxacin1.9810362.21318.20261.15
17.Sulfamerazine2.0020265.08156.0392.08
18.Cefalonium2.01100459.16337.03123.10
19.Oxytetracycline2.0225461.27426.15443.32
20.Ciprofloxacin2.0420332.18288.22245.15
21.Cefacetrile2.09300362.07258.08178.01
22.Tulathromycin A2.11100806.65577.42420.31
23.Tetracycline2.2125445.28154.07427.32
24.Danofloxacin2.2320358.22340.16314.21
25.Enrofloxacin2.3210360.29316.22245.13
26.Orbifloxacin2.3510396.22352.17226.12
27.Thiamphenicol*2.38200354.16290.04184.98
28.Sulfamethazine2.3910279.23186.08124.08
29.Sulfamethizole2.5210271.17156.02108.02
30.Sulfamethoxypyridazine2.5610281.14156.03126.07
31.Sarafloxacin2.5910386.20342.20368.15
32.Difloxacin2.6510400.23356.17299.13
33.Cefazolin2.75100455.10323.06295.09
34.Spiramycin2.96200843.64540.36699.48
35.Pirlimycin3.0520411.32363.18327.21
36.Chlortetracycline3.0825479.27154.07371.06
37.Sulfachlorpyridazine3.1220285.05156.03108.09
38.Gamithromycin3.28100777.63619.52601.45
39.Sulfadoxine3.3910311.17156.03108.09
40.Sulfamethoxazole3.4620254.18155.98147.06
41.Cefoperazone3.52100646.26143.07148.02
42.Florfenicol*3.55200356.10336.02184.98
43.Sulfaethoxypyridazine3.5620295.17267.07156.03
44.Tilmicosin3.64100869.72696.50522.42
45.Sulfisoxazole3.7620268.14156.03113.10
46.Oxolinic acid3.945262.10244.06215.96
47.Chloramphenicol*4.00200321.16151.99257.04
48.Ceftiofur4.1150524.14241.08125.24
49.Erythromycin4.3125734.64576.40558.38
50.Sulfadimethoxine4.3610311.17156.09108.09
51.Sulfaquinoxaline4.4220301.18156.04108.02
52.Tylosin**4.67100916.62772.49598.36
53.Penicillin G5.07100335.18176.07160.07
54.Flumequine5.345262.15244.11202.03
55.Penicillin V5.56100351.10160.06114.07
56.Oxacillin5.99100402.15160.05114.06
57.Virginiamycin M16.1350526.43508.31355.10
58.Tylvalosin6.19501042.71814.46640.39
59.Cloxacillin6.39100436.15277.06160.05
60.Nafcillin6.6025415.19199.09171.06
61.Dicloxacillin6.96100470.11160.05311.02
*Acquired in negative ion mode
ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:35 °C
Standard/Sample
Diluent:Water
Conc.:5–300 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
4.500.46535
7.000.44555
7.010.49010
9.000.49010
DetectorMS/MS
Ion Mode:ESI+/ESI-
Mode:Scheduled MRM
InstrumentUHPLC
Notes1. Positive and negative polarity data were collected simultaneously from a single injection.
2. Amphenicol compounds (chloramphenicol, thiamphenicol, and florfenicol) were detected with negative polarity.
3. The MRM was scheduled at +/- 20 to 30 seconds for each analyte.
4. Multiclass antibiotics include penicillin, cephalosporin, tetracycline, sulfonamide, macrolide, lincosamide, streptogramin, amphenicol, and quinolone.
**The retention time for Tylosin is noted in the peak list; however, it was not included in the chromatogram.

Figure 1 : Antibiotiques Macrolide, Lincosamide, et Streptogramine sur Raptor C18 par LC-MS/MS

cgarm-img
LC_FS0502
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Tildipirosin1.01200734.59561.45204.15
2.Lincomycin1.1150407.32359.23389.28
3.Tulathromycin A1.19100806.65577.42420.31
4.Spiramycin1.41200843.64540.36699.48
5.Pirlymycin1.4920411.32363.18327.21
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
6.Gamithromycin1.50100777.63619.52601.45
7.Tilmicosin1.58100869.72696.50522.42
8.Erythromycin1.8025734.64576.40558.38
9.Tylosin1.87100916.62772.49598.36
10.Tylvalosin2.30501042.71814.46640.39
11.Virginiamycin M12.4550526.43508.31355.10
ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:20–200 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.000.42080
3.010.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC

Figure 2 : Antibiotiques Amphénicol et Tétracycline sur Raptor C18 par LC-MS/MS

cgarm-img
LC_FS0504
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Oxytetracycline1.2825461.27426.15443.32
2.Tetracycline1.3425445.28154.07427.32
3.Thiamphenicol*1.48200354.16290.04184.98
4.Chlortetracycline1.5625479.27154.07371.06
5.Florfenicol*1.86200356.10336.02184.98
6.Chloramphenicol*1.95200321.16151.99257.04
*Acquired in negative ion mode.
ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:25–200 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.000.42080
3.010.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+/ESI-
Mode:MRM
InstrumentUHPLC
NotesTetracyclines and amphenicols were analyzed with ESI+ and ESI- mode, respectively.

Figure 3 : Antibiotiques Quinolone sur Raptor C18 par LC-MS/MS

cgarm-img
LC_FS0505
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Marbofloxacin1.2810363.2072.11320.10
2.Norfloxacin1.3220320.23276.20233.13
3.Ofloxacin1.3210362.21318.20261.15
4.Ciprofloxacin1.3520332.18288.22245.15
5.Danofloxacin1.4020358.22340.16314.21
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
6.Enrofloxacin1.4410360.29316.22245.13
7.Orbifloxacin1.4710396.22352.17226.12
8.Sarafloxacin1.5510386.20342.20368.15
9.Difloxacin1.5710400.23356.17299.13
10.Oxolinic acid2.235262.10244.06215.96
11.Flumequine2.785262.15244.11202.03
ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:5–20 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.000.44060
3.010.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC

Figure 4 : Antibiotiques Pénicilline, Céphalosporine et Tétracycline sur Raptor C18 par LC-MS/MS

cgarm-img
LC_FS0500
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Desacetyl cephapirin0.68150382.03111.92124.21
2.Amoxicillin0.89100366.24349.10208.07
3.Cephapirin1.0550424.17292.08124.14
4.Desfuroyl ceftiofur cysteine disulfide1.06300549.16183.02126.00
5.Cefquinome1.16200529.19134.10125.12
6.Ampicillin1.1850350.19106.07160.06
7.Cefalexin1.19100348.10158.05174.05
8.Oxytetracycline1.2650461.27426.15443.32
9.Cefalonium1.29100459.16337.03123.10
10.Tetracycline1.3250445.28154.07427.32
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
11.Cefacetrile1.37300362.07258.08178.01
12.Cefazolin1.50100455.10323.06295.09
13.Chlortetracycline1.5450479.27154.07371.06
14.Cefoperazone1.69100646.26143.07148.02
15.Ceftiofur1.8550524.14241.08125.24
16.Penicillin G2.18100335.18176.07160.07
17.Penicillin V2.33100351.10160.06114.07
18.Oxacillin2.44100402.15160.05114.06
19.Cloxacillin2.56100436.15277.06160.05
20.Nafcillin2.6325415.19199.09171.06
21.Dicloxacillin2.76100470.11160.05311.02
ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:25–300 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.000.42080
3.010.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC

Figure 5 : Antibiotiques Sulfonamide sur Raptor C18 par LC-MS/MS

cgarm-img
LC_FS0501
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Sulfanilamide0.83200172.9893.0775.23
2.Sulfadiazine1.4520251.18156.0492.08
3.Sulfathiazole1.6010256.16156.0392.08
4.Sulfapyridine1.6710250.13156.1092.08
5.Sulfamerazine1.7920265.08156.0392.08
6.Sulfamethazine2.0710279.23186.08124.08
7.Sulfamethizole2.1110271.17156.02108.02
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
8.Sulfamethoxypyridazine2.1610281.14156.03126.07
9.Sulfachlorpyridazine2.5520285.05156.03108.09
10.Sulfadoxine2.7510311.17156.03108.09
11.Sulfamethoxazole2.7820254.18155.98147.06
12.Sulfaethoxypyridazine2.8420295.17267.07156.03
13.Sulfisoxazole2.9820268.14156.03113.10
14.Sulfadimethoxine3.3710311.17156.09108.09
15.Sulfaquinoxaline3.4020301.18156.04108.02
ColumnRaptor C18 (cat.# 9304A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor C18 EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9304A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water
Conc.:10–200 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.1% Formic acid in water
B:0.1% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.49010
3.500.46040
3.510.49010
5.000.49010
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC

Figure 6 : Antibiotiques Ionophores sur Raptor Biphenyl par LC-MS/MS

cgarm-img
LC_FS0503
PeakstR (min)Conc.
(ng/mL)
Precursor IonProduct IonProduct Ion
1.Lasalocid A1.92100613.42377.28595.40
2.Monensin2.12100693.50675.44461.30
3.Salinomycin2.19100773.57431.24531.39
4.Maduramicin2.30100939.65877.58473.31
5.Narasin2.58100787.59431.27531.35
ColumnRaptor Biphenyl (cat.# 9309A12)
Dimensions:100 mm x 2.1 mm ID
Particle Size:2.7 µm
Pore Size:90 Å
Guard Column:Raptor Biphenyl EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 µm (cat.# 9309A0252)
Temp.:40 °C
Standard/Sample
Diluent:Water:methanol (10:90)
Conc.:100 ng/mL
Inj. Vol.:2 µL
Mobile Phase
A:0.5% Formic acid in water
B:0.5% Formic acid in acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.53565
3.000.52575
3.010.53565
5.000.53565
DetectorMS/MS
Ion Mode:ESI+
Mode:MRM
InstrumentUHPLC
FSSS2276A-FR